Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

INNOVATIVE PHAR (0399.HK)

Compare
0.153
-0.002
(-1.29%)
At close: 3:57:50 PM GMT+8
Loading Chart for 0399.HK
  • Previous Close 0.155
  • Open 0.154
  • Bid 0.150 x --
  • Ask 0.153 x --
  • Day's Range 0.148 - 0.160
  • 52 Week Range 0.148 - 0.290
  • Volume 571,540
  • Avg. Volume 824,781
  • Market Cap (intraday) 278.797M
  • Beta (5Y Monthly) -0.19
  • PE Ratio (TTM) --
  • EPS (TTM) -0.010
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trade of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services, as well as securities investment. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

www.ipb.asia

20

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 0399.HK

View More

Performance Overview: 0399.HK

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0399.HK
26.44%
HANG SENG INDEX (^HSI)
1.15%

1-Year Return

0399.HK
26.44%
HANG SENG INDEX (^HSI)
18.56%

3-Year Return

0399.HK
8.93%
HANG SENG INDEX (^HSI)
9.08%

5-Year Return

0399.HK
38.55%
HANG SENG INDEX (^HSI)
18.24%

Compare To: 0399.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0399.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    282.44M

  • Enterprise Value

    1.13B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    87.85

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    191.96

  • Enterprise Value/EBITDA

    5.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    194.33%

  • Return on Assets (ttm)

    -0.65%

  • Return on Equity (ttm)

    1.76%

  • Revenue (ttm)

    5.89M

  • Net Income Avi to Common (ttm)

    11.46M

  • Diluted EPS (ttm)

    -0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    428k

  • Total Debt/Equity (mrq)

    189.99%

  • Levered Free Cash Flow (ttm)

    -128.15M

Research Analysis: 0399.HK

View More

Company Insights: 0399.HK

Research Reports: 0399.HK

View More

People Also Watch